Chromatin
Pathways in Development and Oncogenesis
In eukaryotic cells, DNA is tightly associated with histones as well as non-histone
proteins to form the chromatin fiber. Specifically, histones are assembled as
octamers composed of two copies of each core histone, H2A, H2B, H3 and H4 in
order to form the nucleosome. Histones are subjected to specific modifications
that modulate the ionic strength of interactions among the components of the
chromatin fiber and dictate the recruitment of additional factors. These specific
modifications result in higher order chromatin structure and thereby define the
level of accessibility to the DNA strand. Therefore higher order chromatin structure
virtually impacts all biological processes related to DNA, including gene expression
and genomic stability, both of which are at the nexus of the transformation process.
The research in our laboratory is focused on histone modifications, and specifically
reversible histone acetylation, as they relate to normal and pathological development
in mammals. More specifically, we study how disruption of the normal histone
deacetylation pathway affects mammalian development in the mouse, and influence
oncogenesis. Several studies suggested that blocking the enzymatic activity of
HDAC complexes (e.g., using histone deacetylase inhibitors) could prevent tumorigenesis
and selectively induce cell death in transformed cells. While HDACs are integral
components of several gene regulatory complexes, HDAC inhibitors developed to
date exhibit little or no specificity towards individual HDAC-containing complex.
Thus, the identification of pathways involved in the modulation of the activities
of specific HDAC complexes is a priority in cancer therapy. Knowledge of these
control mechanisms in both normal physiology and malignancy is essential for
the better understanding of the malignant process that will allow development
of novel therapeutic and diagnostic approaches to human disease. |